Osaka, Japan

Masamitsu Konno

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Masamitsu Konno

Introduction

Masamitsu Konno is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of ligands that target specific transporters in cancer cells. His work is characterized by a focus on enhancing the efficacy of treatments for cancer patients.

Latest Patents

Masamitsu Konno holds a patent for a ligand capable of multivalently binding to a glutamine transporter. This invention is particularly relevant as it addresses the glutamine transporter expressed in excess in cancer cells compared to normal cells. The ligand contains a plurality of groups represented by a specific formula, which enhances its binding capabilities.

Career Highlights

Throughout his career, Masamitsu Konno has been associated with prestigious institutions such as the Tokyo Institute of Technology and Osaka University. His work at these institutions has allowed him to engage in cutting-edge research and contribute to advancements in cancer treatment methodologies.

Collaborations

Masamitsu Konno has collaborated with notable colleagues, including Nobuhiro Nishiyama and Hiroyasu Takemoto. These collaborations have further enriched his research and have led to significant advancements in the understanding of glutamine transporters.

Conclusion

Masamitsu Konno's innovative work in the field of biochemistry, particularly his patent for a ligand targeting glutamine transporters, showcases his commitment to advancing cancer treatment. His collaborations and career highlights reflect his dedication to research and innovation in this critical area of health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…